Back to search

Article

Review of the Fluoropyrimidine Antidote Uridine Triacetate

2024-09-02

Abstract excerpt

not-yet-known not-yet-known not-yet-known unknown In 2015, the United States Food and Drug Administration (FDA) approved uridine triacetate to treat overdose and severe toxicity of the fluoropyrimidine chemotherapy agents 5-fluorouracil (5-FU) and its oral prodrug capecitabine. Uridine triacetate is as an oral prodrug of uridine which competes with cytotoxic fluoropyrimidine metabolites for incorporation into...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a8aa8b44-b917-5a46-afe8-5875f1986ee5
DOI
10.22541/au.172526739.97846727/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Review of the Fluoropyrimidine Antidote Uridine TriacetateDOI 10.22541/au.172526739.97846727/v1
Select a neighboring publication to make it the new centre.